TD BUY $YRD at 14.68, Supp 14.36 Resis 17.02 R19 HiLo 31% T1Y 17 hold 2.9 PE 5.5 DIV N/A #Yirendai L #stocks #trading #finance #market

2019-06-08
70 Views

TD BUY detected for YRD (Yirendai Ltd.) at the close price of 14.68 with a support level at 14.36 and a resistance at 17.02, providing an opportunity for a 19 % return. Trading at a 31 % level between the 52week High (25.76) and 52 week Low (9.61). The average analyst 1-year target price is 17.0 with an average hold and a score of 2.9.

TD Buy
19 %
YRD
14.68
Yirendai Ltd.
HiLo
31.4 %
Support
14.36
Resistance
17.02
Target1Y
17.00
Rated
hold
Score
2.9
52week high
25.76
52week low
9.61
50DMA
15.33
200DMA
14.92
10DMA
15.56
20DMA
15.84
100DMA
13.82
Volume
76062
AvgDayVol
235254
MarketCap
903282432
EBITDA
0
Revenue
0
PE
5.53
P2S
0.00
P2B
0.00
Dividend
0.56
Div Ex-Date
2018-04-27 00:00:00

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

#GoldenCross $G1A.DE at 26.67 R7  HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP  #DAX #Aktien #Boerse #stocks
Bull, Europe, Germany
14 views
Bull, Europe, Germany
14 views

#GoldenCross $G1A.DE at 26.67 R7 HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP #DAX #Aktien #Boerse #stocks

Andreas Aigner - 2019-09-19

Golden Cross detected for G1A.DE (GEA GROUP AG) at the close price of 26.67. Trading at a 54 % level…

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9  HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading
Bear, Europe, Financial Services
10 views
Bear, Europe, Financial Services
10 views

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9 HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading

Andreas Aigner - 2019-09-19

TD SELL detected for DLG.L (DIRECT LINE INSURANC) at the close price of 305.40 with a support level at 279.90…

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.